Mumbai (Maharashtra) [India], September 14 (ANI): Equity benchmark indices traded firm during early hours on Monday on the back of positive global cues as hopes of a coronavirus vaccine were rekindled after AstraZeneca resumed its phase three trial.

At 10:15 am, the BSE S&P Sensex was up by 273 points or 0.7 per cent at 39,127 while the Nifty 50 gained by 69 points or 0.6 per cent at 11,534.

Also Read | Suriya To Be Held In Contempt of Court After NEET Exams and Virtual Court Hearings Comment?.

Except for Nifty pharma and FMCG. all sectoral indices at the National Stock Exchange were in the positive zone with Nifty IT gaining by 2.2 per cent and realty by 3.1 per cent.

Among stocks, HCL Technologies spurted by 6.3 per cent to Rs 765 per share while Tech Mahindra moved up by 2.7 per cent, Tata Consultancy Services by 1.8 per cent, Infosys by 1.7 per cent and Wipro by 1.6 per cent.

Also Read | Ayushmann Khurrana Birthday: 5 Characters Played By This National Award-Winning Actor That Won Hearts!.

Realty major DLF ticked up by 2.1 per cent to Rs 157.55 per share while Oberoi Realty advanced by 4 per cent to Rs 392. The others which gained were Tata Motors, Adani Ports and HDFC.

However, those which lost were Asian Paints, Bajaj Finance, Hero MotoCorp, Maruti and Bharti Infratel.

Meanwhile, Asian shares firmed on renewed hopes for a coronavirus vaccine after AstraZeneca resumed its phase three trial though sentiment was still cautious.

MSCI's broadest index of Asia Pacific shares outside Japan was up by 0.7 per cent. Japan's Nikkei added 0.7 per cent while Chinese shares started firm with the blue-chip index rising by 0.6 per cent. (ANI)

(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)